Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinomaTae Hyun Kim, Chang‐Min Kim, Joong‐Won Park et al.|Oncotarget|2017Cited by 22
Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinomaDoo Yeul Lee, Chang‐Min Kim, Joong‐Won Park et al.|Strahlentherapie und Onkologie|2015Cited by 14
Development of 3D-iNET ORION: a novel, pre-clinical, three-dimensional in vitro cell model for modeling human metastatic neuroendocrine tumor of the pancreasJán Strnádel, Michael Bouvet, Mark A. Valasek et al.|Human Cell|2024Cited by 2
Supplementary Figure S5 from Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal AdenocarcinomaSang Myung Woo, Soo‐Youl Kim, Joon Hee Kang et al.|Unknown|2026Cited by 0
Supplementary Figure S2 from Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal AdenocarcinomaSang Myung Woo, Soo‐Youl Kim, Joon Hee Kang et al.|Unknown|2026Cited by 0